Pinealon
ResearchPinealon
- Category
- Cognitive & Neuroprotection
- Aliases
- Glu-Asp-Arg tripeptide
- Administration
- Intranasal (research), Subcutaneous injection (research)
Timing
A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.
- 1
1–2 Weeks
Effects are generally described as subtle, consistent with its proposed cellular-level mechanism.
- 2
3–4 Weeks
Some users report a modest sense of improved mental clarity.
- 3
5–7 Weeks
Continued use is generally associated with a steady rather than building effect.
- 4
8–10 Weeks
Limited human data makes a longer-term felt timeline difficult to characterize.
- 5
11–15 Weeks
Available evidence does not describe outcomes at this duration.
- 6
16–20 Weeks
No well-established human timeline exists to reference at this stage.
- 7
21–24 Weeks
Any effect assessment at this duration would rely on personal observation given limited research.
⚠️ Research context only. This is not medical advice and results are not guaranteed.